IL6 and cancer: One of the events downstream of NF-κB activation is production of various cytokines and chemokines (e.g. IL-6, and IL-17) that attract leukocytes [41], which results in enhanced tumor progression, cancer cell growth and spread, angiogenesis, invasion and tumor immunosuppression [24,25].